Cost Analysis Monotherapy of Type 2 Diabetes Mellitus Patients in RSUD. Prof. Dr. Margono Soekarjo

Fajar Wahyu Pribadi, Afifah, Catharina Widiartini

2020

Abstract

Type 2 Diabetes Mellitus (D.M.) is a metabolic syndrome characterized by hyperglycemia due to decreased insulin sensitivity. High prevalence and long-term treatment to be burdened on the health economy indicate that D.M. therapy must be cost-effective. The study aimed to know the cost analysis monotherapy of type 2 Diabetes Mellitus patients. Twenty-three patients without complications were given monotherapy and followed six months from D.M.'s initial diagnostic in a descriptive study. Data was taken from medical records, clinical pathology laboratory and finansial data between January 1, 2016, and June 30, 2018. The cost analysis therapy was compared between monotherapy Insulin, Metformin, Glimepiride and Pioglitazone. Of the 23 patients monotherapy of the study population, nine patients received Insuline; 8 patients received Metformin; 3 patients received Glimepirid, and three patients received Pioglitazone. The analysis showed that the total cost INA-CBG's rates Rp9.0189 million; Rp7.9648 million; Rp2.9609 million and Rp2.9633 million. Effectiveness therapy rates 44.44%; 70.83%; 50% and 66.67%. CER Rp202925; Rp112444; Rp59218 and Rp44449. As a conclusion, Pioglitazone is more cost-effective when compared to Insulin, Metformin and Glimepiride. Our findings suggest it needed to assess the total costs effectiveness of therapy with more and longer periods.

Paper Citation

in Harvard Style

Pribadi F., Afifah. and Widiartini C. (2020). Cost Analysis Monotherapy of Type 2 Diabetes Mellitus Patients in RSUD. Prof. Dr. Margono Soekarjo.In Proceedings of the 1st Jenderal Soedirman International Medical Conference in conjunction with the 5th Annual Scientific Meeting (Temilnas) Consortium of Biomedical Science Indonesia - Volume 1: JIMC, ISBN 978-989-758-499-2, pages 81-83. DOI: 10.5220/0010488100810083

in Bibtex Style

@conference{jimc20,
author={Fajar Wahyu Pribadi and Afifah and Catharina Widiartini},
title={Cost Analysis Monotherapy of Type 2 Diabetes Mellitus Patients in RSUD. Prof. Dr. Margono Soekarjo},
booktitle={Proceedings of the 1st Jenderal Soedirman International Medical Conference in conjunction with the 5th Annual Scientific Meeting (Temilnas) Consortium of Biomedical Science Indonesia - Volume 1: JIMC,},
year={2020},
pages={81-83},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0010488100810083},
isbn={978-989-758-499-2},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st Jenderal Soedirman International Medical Conference in conjunction with the 5th Annual Scientific Meeting (Temilnas) Consortium of Biomedical Science Indonesia - Volume 1: JIMC,
TI - Cost Analysis Monotherapy of Type 2 Diabetes Mellitus Patients in RSUD. Prof. Dr. Margono Soekarjo
SN - 978-989-758-499-2
AU - Pribadi F.
AU - Afifah.
AU - Widiartini C.
PY - 2020
SP - 81
EP - 83
DO - 10.5220/0010488100810083